• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 16, 2024 at 10:02: AM
via Merck announced that the FDA has granted approval to its blockbuster anti-PD-1 therapy, Keytruda, for expanded use in cervical cancer. The approval is for Keytruda plus chemoradiotherapy (CRT) for the treatment of patients with FIGO (International Federation of Gynecology and Obstetrics) 2014 Stage III-IVA cervical cancer.

article source
 

<



Similar threads

cafead
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Replies
0
Views
167
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Merck (MRK) Q2 Earnings and Revenues Top Estimates
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Merck (MRK) Reports Q2 Loss, Tops Revenue Estimates
Replies
0
Views
75
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Merck (MRK) Q2 Earnings and Revenues Surpass Estimates
Replies
0
Views
121
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Can Merck (MRK) Keep the Earnings Beat Streak Alive in Q3?
Replies
0
Views
181
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote